Nicholas Sarlis, MD, PhD, FACP

Nicholas J. Sarlis, MD, PhD, FACP, is a prominent figure in the biotechnology and oncology fields, currently serving as the Chief Medical Officer (CMO) and Head of Clinical Development at Cleara Biotech B.V. since February 2023. His role involves overseeing the clinical development of innovative therapies targeting "scarred" cellular senescence, particularly in late-stage cancer and chronic diseases.14

Professional Background

Dr. Sarlis has over 25 years of experience in clinical and pharmaceutical settings. His career highlights include:

• Leadership Positions: He has held senior roles such as CMO at Sellas Life Sciences Group and The Lynx Group, where he led the clinical development of peptide-based cancer vaccines.12
• Medical Affairs: Before joining Cleara, he was Head of Medical Affairs at Incyte Corporation and led medical content functions at Amplity Health.13
• Clinical Research: He has been involved in managing medical strategies for the launch of six globally marketed products and has participated as a site investigator in numerous studies.1

Education and Credentials

Dr. Sarlis earned his Doctor of Medicine and DrMedSci degrees from the University of Athens, Greece, and holds a PhD from Imperial College London. He is certified by the American Board of Internal Medicine and is an elected Fellow of both the American College of Physicians and the Royal Society of Medicine in the UK.12

Contributions to Oncology

Dr. Sarlis is recognized for his contributions to oncology research and has published extensively, with over 135 articles and textbook chapters to his name. His expertise spans clinical trials, regulatory affairs, and translational research within academic centers.12

In summary, Dr. Nicholas Sarlis is a highly experienced medical professional with a significant background in oncology and biotechnology, making him a key asset to Cleara Biotech's mission to develop innovative treatments for serious health conditions.